Cipla Ltd News

Drugmakers Lupin Ltd and Cipla Ltd will make way for the two banks, according to a statement from Asia Index Pvt Ltd. 

Delhi High Court today told the government not to take any coercive action against pharma companies, including Novartis India Limited and Cipla Ltd, in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.

Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world`s largest generics market.

Shares of drug major Cipla Monday pared early gains on profit-booking, falling 5 percent, even as the company reported an over two-fold jump in consolidated net profit for the quarter ended June 30, 2015.

Drug major Cipla has re-negotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals and now decided to pay USD 26 million (around Rs 166 crore) upfront to the shareholders of the African firm.

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Pharmaceutical firm Cipla Ltd on Thursday reported 15.31 percent increase in its consolidated net profit at Rs 327.85 crore in the third quarter ended December 31, 2014.

Drug major Cipla's subsidiary has bagged an order worth 2 billion rand (around Rs 1,100 crore) for HIV drugs from the South African government.

Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.

Pharma major Cipla Ltd has sought adoption of a pragmatic Intellectual Property Rights (IPR) policy including in-licensing within the present framework of its international obligations.